Provisión de tratamiento del VHB, VHC y del VIH en prisión para reducir la transmisión | www.emcdda.europa.eu

Best practice portal main page

Summary of the evidence

Rating: Beneficioso

En una revisión sistemática (ECDC/EMCDDA, 2018) se halló que el tratamiento del VHB, el VHC y el VIH en prisión era efectivo en:

la reducción de la transmisión del VHB, VHC y del VIH.

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option

Suministro de tratamiento del VHB, VHC y del VIH en prisión

Desired outcome(s)

reducir las enfermedades infecciosas

Area(s)

Tratamiento

Specific substance or pattern of use

no-drogas específicas

Target group(s) or setting(s)

prisión

References

European Centre for Disease Prevention and Control, European Monitoring Centre for Drugs and Drug Addiction. Public health guidance on prevention and control of blood-borne viruses in prison settings. Stockholm: ECDC and EMCDDA; 2018.

Explore all resources in the Best practice portal

Briefings

A one-stop-shop for anyone planning or delivering health and social responses.

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

Evidence

All of the latest research and evidence on drug-related interventions.

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice